(Q90858645)
Statements
Rates of ERBB2 Alterations across Melanoma Subtypes and a Complete Response to Trastuzumab Emtansine in an ERBB2-Amplified Acral Melanoma (English)
Lee S Gottesdiener
Shannon O'Connor
Klaus J Busam
Helen Won
David B Solit
David M Hyman
Alexander N Shoushtari